Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SynAct Pharma Major Shareholding Notification 2023

Nov 15, 2023

3114_iss_2023-11-15_50bab4ca-ad92-450c-a222-c4cec3eea09d.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Issuer SynAct Pharma AB

Holder

Thomas Jonassen

Instrument

Instrument Ordinary SE0008241491
Before the transaction
Shares 4,722,276
Voting rights 4,722,276
Transaction
Reason for major shareholding notification Sell
Date 10/11/2023
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 1,190,632
Directly held voting rights 0
Indirectly held voting rights 1,190,632
Percentage
Directly held shares 3.3472 %
Directly held voting rights 0 %
Indirectly held voting rights 3.3472 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 3.3472 % 1,190,632
paragraph, line 2 Instruments - FITA Ch. 4, section 2, first
first paragraph, line 3 Instruments - FITA Ch. 4, section 2,
- Physically settled
- Cash settled
Total 3.3472 % 1,190,632
Chain
of
controlling companies
Voting rights % Voting rights Company
1,161,777 3.26608
28,855 0.08112 Goodwind Holding Gmbh
TJ Biotech Holding ApS
Group
total
holdings
Voting rights
1,190,632
Percentage of voting rights 3.3472
Published
15/11/2023 11:04

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25